Miglustat
Spezifikationen
72599-27-0CAS-Nummer
689-232-7EG-Nummer
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triolIUPAC-Name
C10H21NO4Chemische Formel
219.28 g/molMolekulargewicht
Miglustat; 72599-27-0; Zavesca; N-Butyldeoxynojirimycin; (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol; NB-DNJ; Butyldeoxynojirimycin; N-Butylmoranoline; N-butyl-1-deoxynojirimycin; BuDNJ; n-Butyl deoxynojirimycin; N-(n-Butyl)deoxynojirimycin; SC-48334; OGT-918; miglustatum; SC 48334; OPFOLDA; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R,3r,4R,5S)-; DTXSID6045618; ADN3S497AZ; N-(n-butyl)deoxy-nojirimycin; DTXCID4025618; CHEBI:50381; 1,5-(BUTYLIMINO)-1,5-DIDEOXY-D-GLUCITOL; Yargesa; RefChem:57017; A16AX06; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-,(2R-(2alpha,3beta,4alpha,5beta))-; 689-232-7; OGT 918; N-Butyl-DNJ; CHEMBL1029; n-Butyl dnj; MFCD00272581; Miglustat [USAN]; N-Butyl-deoxynojirimycin; Vevesca; N-Butyldeoxynojirimycin;NB-DNJ;OGT918; NBV; Zavesca (TN); CAS-72599-27-0; N-Bu-DNJ; UNII-ADN3S497AZ; SC48334; Brazaves; Miglustat [USAN:INN:BAN]; D-Glucitol, 1,5-(butylimino)-1,5-dideoxy-; NCGC00018140-02; 72599-27-0 (free base); Brazaves (TN); Opfolda (TN); MIGLUSTAT [INN]; MIGLUSTAT [JAN]; MIGLUSTAT [MI]; 1,5-Dideoxy-1,5-N-butylimino-D-glucitol; MIGLUSTAT [VANDF]; MIGLUSTAT [MART.]; MIGLUSTAT [WHO-DD]; N-(n-butyl)-1,5-dideoxy-1,5-imino-D-glucitol; MIGLUSTAT [EMA EPAR]; Miglustat (JAN/USAN/INN); SCHEMBL246893; GTPL4841; orb1183163; orb1217697; orb1309423; MIGLUSTAT [ORANGE BOOK]; BDBM18355; N-(n-Butyl)-1-deoxynojirimycin; UQRORFVVSGFNRO-UTINFBMNSA-N; GLXC-15328; HMS2090N20; Tox21_110830; (2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)-3,4,5-piperidinetriol; EBC-07860; AKOS028109118; Tox21_110830_1; DB00419; MB06729; 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-; NCGC00024452-03; NCGC00024452-04; DA-65462; HY-17020; N-(n-Butyl)-1-deoxynojirimycin min. 99%; NS00003211; N-Butyldeoxynojirimycin, film (dried in situ); D05032; P16976; T12039; AB00489939-10; Q425911; SR-01000000043; SR-01000000043-2; BRD-K33251802-001-01-3; Z2379810058; 134282-77-2Synonyme
Produkte, die Miglustat enthalten
자베스카캡슐100밀리그램(미글루스타트)ブレーザベスカプセル100mgオプフォルダカプセル65mgZAVESCA 100 MG CAPSULAS DURASYARGESA 100 MG CAPSULAS DURAS EFGOPFOLDA 65 MG CAPSULAS DURASMIGLUSTAT WAYMADE 100 MG CAPSULAS EFGMIGLUSTAT GEN.ORPH 100 MG CAPSULAS DURAS EFGMIGLUSTAT DIPHARMA 100 MG CAPSULAS DURAS EFGMIGLUSTAT ACCORD 100 MG CAPSULAS DURAS EFGZAVESCA 100 mg, gélulesYARGESA 100 mg, gélule
Seite 1 von 2
Unternehmen, die Miglustat verkaufen
GE
GEN.ORPHFranceSI
Sinoway Industrial Co.Ltd.ChinaZA
Zhejiang Ausun PharmaceuticalChinaAH
Accord Healthcare S.L.U.Spain(주
(주)한국얀센Republic of Koreaヤン
ヤンセンファーマ株式会社JapanAP
ADVANZ PHARMA LIMITEDFranceSeite 1 von 2